Skip to main content
Equibles

TLX · Telix Pharmaceuticals Ltd

Track TLX — free

Use TLX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TLX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.98 +0.10 (+0.92%)
Rebalance outlook locked
Market Cap
$3.88B
Shares
338.78M
Volume · Oct 5 235.29K Avg daily vol (3M) 247.39K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$10.88 Open$10.80 Day$10.79–10.91 52W close$6.41–12.83 Avg vol 30d387K Short int353K · 0.1% float · 1.0d Short vol47% Last earningsAug 19, 2026 DataNov 2024–Oct 2026

Up next

Next earnings call
Nov 17, 2026 Est · unconfirmed · in 6 wks
Q4 2025 earnings call transcript
call held Feb 20, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
+3.2%
Trailing year
Short interest
0.1%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Bullish Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.5 · calm Equity put/call 0.59
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +13%
above
Price vs 50-day avg −4%
below
RSI (14) 45
neutral
MACD trend Negative
52-week position 70%
mid-range
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Weak
1-month return −9%
trailing
6-month return +2%
trailing
YTD return +45%
this year
Relative strength −10%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $11 › 200d $10 — 50d above 200d
Institutional flow Accumulating
+55% holders QoQ · +24 funds added
Insider flow Accumulating
Net +$20.0K over 90 days · 0% sells
Short interest Rising
0.10% of float · ▲ +33.1% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
62 holders — near 2-yr high, broad support
Squeeze score 37
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 56%
annualized · 1-yr
Max drawdown −42%
past year
ATR 4.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
1 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+13% Bullish
Price vs 50-day avg
−4% Neutral
RSI (14)
45 Neutral
MACD trend
Negative Bearish
52-week position
70% Neutral
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $11 › 200d $10 — 50d above 200d
Institutional flow Accumulating
+55% holders QoQ · +24 funds added
Insider flow Accumulating
Net +$20.0K over 90 days · 0% sells
Short interest Rising
0.10% of float · ▲ +33.1% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
62 holders — near 2-yr high, broad support
Price context
position in its 52-week range
Range low $6 Now $11 · 70% Range high $13
vs 200-day avg +13% vs 50-day avg -4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
TLX
Telix Pharmaceuticals Ltd
this stock
$3.88B +45.3% — — 0.1%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $133.37B +11.1% +46.2% 30.7 1.9%
REGN
Regeneron Pharmaceuticals, Inc.
 $81.13B -5.9% +20.8% 19.5 2.5%
MRNA
Moderna, Inc.
 $79.40B +589.1% +4.3% — 8.2%
CSLLY
Csl Ltd
 $61.25B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
62
% held
0.9%
Net QoQ
+608.7K sh
Top holder
FMR LLC
Held Float
View
Held by Funds
Fund positions
5
View
Short & Settlement
Short Interest Rising
Shares short
352.5K
Days to cover
1.0d
Change
+87.6K sh
View
Short Volume
Short vol %
47%
As of
Oct 5, 2026
Short Total
View
Fails to Deliver
FTD shares
15.7K
Value
$177.4K
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
45.8%
Week of
Aug 31, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$20.0K
Buyers / Sellers
1 / 0
Buyers Sellers
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 30, 2026
This year
30
View
Earnings & Events
Webcasts
Last webcast
Sep 20, 2026
View

Performance

5D 20D 120D MTD YTD
TLX -6.4% -8.9% +1.7% -0.8% +45.3%
SPY +1.2% +0.6% +11.6% +1.6% +13.6%
vs SPY -7.6% -9.5% -9.9% -2.4% +31.6%
Key facts CIK 2007191 CUSIP 87961M105 13F (30d) 1 filings 1 filers Visit website Investor relations